Market Overview

As the US markets prepare to open, key indices are showing positive pre-market movement:

• S&P 500 (ES): +0.2%
• NASDAQ 100 (NQ): +0.3%
• Russell 2000 (RTY): +0.2%

Several individual stocks are experiencing significant pre-market activity based on recent earnings reports, guidance updates, and other market-moving news.

Notable Pre-Market Movers

Stocks Declining:

• Akamai Technologies ($AKAM): -7%
• Akamai’s revenue came in lighter than expected, and both its next quarter and full-year outlooks were disappointing.
• Progyny ($PGNY): -25%
• The company missed top-line expectations, with a light revenue view for the next quarter and a cut in its full-year guidance.
• Moderna ($MRNA): -2%
• Moderna informed that the FDA, due to administrative constraints, will not complete its review of the MRNA-1345 by the PDUFA date of May 12.

Stocks Gaining:

• H&R Block ($HRB): +2.5%
• H&R Block reported an earnings per share (EPS) and revenue beat.
• Guardant Health ($GH): +9%
• The company reported a shallower loss per share, beat revenue expectations, and lifted its top-line guidance.
• Natera ($NTRA): +17%
• Natera posted a shallower loss per share, topped revenue expectations, and raised its full-year revenue outlook.
• CRH plc ($CRH): +4%
• CRH surprised the market with higher profit per share and topped revenue expectations.
• Victoria’s Secret ($VSCO): +13.5%
• The retailer announced an upside preliminary Q1 announcement.
• Novavax ($NVAX): +120%
• Novavax signed a significant licensing agreement with Sanofi ($SNY), driving a massive surge in its stock price.
• 3M Company ($MMM): +1%
• 3M was upgraded by HSBC, contributing to its pre-market gain.

Today’s pre-market activity highlights a mix of reactions to earnings beats and misses, guidance updates, and significant corporate announcements. Investors are particularly optimistic about companies like Novavax, which saw a substantial gain following a licensing agreement, and Guardant Health, which impressed with its updated guidance. Conversely, companies like Akamai and Progyny are facing challenges due to lighter-than-expected financial outlooks.

As the market opens, these pre-market trends will be key indicators to watch for broader market sentiment and potential trading opportunities throughout the day.